OLMA - Financial Reports List - Olema Pharmaceuticals, Inc. - IntrinsicAlpha

Olema Pharmaceuticals, Inc. OLMA

Healthcare - Biotechnology - NASDAQ - US

$ 4.75

7.47 %

$ 325 M

Market Cap

-2.16

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-25.38%	-20.88%
Annual Report	FY	10-K	2024-12-31	0.00%	-33.95%	-35.53%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-60.71%	-61.17%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-51.19%	-55.22%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-14.83%	-16.00%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-6.50%	-11.75%
Annual Report	FY	10-K	2023-12-31	0.00%	5.78%	1.89%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	3.22%	-0.52%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	38.84%	35.12%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-18.26%	-27.30%

1